Skeptics may have an extra reason to reconsider the upshots of vaccines: Two recent studies showed that flu and pneumonia vaccines reduced people’s risk…
Super-agers don’t develop the key biomarkers of Alzheimer’s, even in their 80s and 90s. Scientists try to crack the code about what protects their…
If aducanumab — an experimental treatment that may slow the progression of Alzheimer’s — gets FDA approval, how will the healthcare system meet the anticipated…
Should people seek genetic testing — with their doctor or via an at-home kit like 23andMe — for Alzheimer’s? And if they do, how…
All photos courtesy of Mary Lou Grace Robison. Main image: “Crumbling,” published in The Ignatian Literary Magazine Mary Lou Grace Robison only picked up…
Shedding further light on the mystery of Alzheimer’s pathology, a new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia…
While Biogen’s experimental Alzheimer’s treatment aducanumab faced yet another snag recently in its convoluted path toward FDA approval, other drugs companies are catching up:…